Welcome to our dedicated page for Healthcare Tr Amer SEC filings (Ticker: HR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare Realty Trust Incorporated filings document its REIT business, medical outpatient building portfolio, operating partnership financing and public-company governance. Form 8-K reports cover material agreements and other events involving Healthcare Realty Holdings, L.P., senior unsecured indebtedness, exchangeable senior notes, commercial paper, Regulation FD presentations, auditor changes and executive appointments.
Proxy materials provide board, executive compensation, equity award, shareholder voting and governance disclosures. Other event and results filings address operating and financial performance, capital structure and corporate reporting matters related to the company’s U.S. outpatient medical real estate platform.
Healthcare Realty Trust Inc.: Cohen & Steers filed Amendment No. 2 to Schedule 13G reporting beneficial ownership of 56,429,507 shares of common stock, representing 16.05% of the class as of 09/30/2025. Cohen & Steers, Inc. reports sole voting power over 42,824,616 shares and sole dispositive power over 56,429,507 shares.
Subsidiaries reported stakes include Cohen & Steers Capital Management, Inc. with 55,840,490 shares (15.88%), Cohen & Steers UK Limited with 544,974 shares (0.15%), and Cohen & Steers Ireland Limited with 44,043 shares (0.01%). The filing certifies the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Healthcare Realty Trust (HR) reported Q3 2025 results. Total revenues were $297.8 million, down from $315.4 million a year ago, as rental income eased to $287.4 million from $306.5 million. The company recorded a net loss attributable to common stockholders of $57.7 million versus a $93.0 million loss last year, as property impairments and interest expense continued to weigh on results.
Portfolio recycling accelerated. Year-to-date real estate dispositions reached $477.6 million in sale price, generating $447.3 million of net proceeds and $75.5 million of gains. Assets held for sale grew to 43 properties and two land parcels, with $604.7 million classified as held for sale, reflecting an ongoing pruning strategy.
Non-cash charges remained significant. The company recognized $104.4 million of real estate impairments in Q3 and $255.4 million year-to-date. Q3 interest expense was $52.6 million.
Balance sheet updates. HR repaid $250 million senior notes in May and entered a new $1.5 billion unsecured revolving credit facility on July 25, 2025, extended to 2029; $149 million was drawn at quarter-end. Operating cash flow for the nine months was $324.8 million. Shares outstanding were 351.6 million as of October 24, 2025.
Healthcare Realty Trust (HR) filed an 8‑K stating it issued a press release announcing its earnings and dividend for the third quarter ended September 30, 2025. The company also furnished its Q3 2025 Supplemental Information. The press release is included as Exhibit 99.1 and the supplemental package as Exhibit 99.2, and both are referenced as available via the company’s website.
Starboard-affiliated funds report holding 14,492,496 shares of Healthcare Realty Trust Inc (HR), equal to 4.1% of the Class A common stock based on 351,606,597 shares outstanding as of July 25, 2025. The filing amends prior disclosures to specify that portions of these holdings were purchased in the open market using working capital and gives aggregate purchase-price amounts by fund: Starboard V&O Fund ~8,007,983 shares for $131,335,340; Starboard S LLC ~1,158,671 shares for $19,016,386; Starboard L Master ~485,662 shares for $7,963,596; Starboard X Master ~2,976,770 shares for $48,949,159; and 1,863,410 shares held in the Starboard Value LP account for ~$32,170,068, all excluding commissions.
The amendment also discloses that Starboard V&O Fund exercised forward purchase contracts with Bank of America to acquire 4,826,156 shares (the BA Forward Contracts) and is no longer a party to those contracts. The filing states that, as of September 23, 2025, the reporting persons ceased to beneficially own more than 5% of the issuer.
Julie F. Wilson, EVP and Chief Administrative Officer and a director of Healthcare Realty Trust Inc. (HR), reported a sale of 15,000 shares of HR common stock on 09/05/2025 at a reported price of $18 per share. After the transaction she beneficially owned 113,419 shares. The Form 4 was submitted under power of attorney by Andrew E. Loope.
Form 144 notice for Healthcare Realty Trust Incorporated (HR) reports a proposed sale of 15,000 shares of common stock through Charles Schwab with an aggregate market value of $262,050. The filing lists 351,606,597 shares outstanding and an approximate sale date of 09/04/2025 on the NYSE. The shares to be sold were acquired as equity compensation: 11,303 shares granted on 12/01/2019 and 3,697 shares granted on 12/01/2022, with payment/vesting events recorded on 12/11/2024. The filer reports no sales of the issuer's securities in the past three months and includes the standard signature representation regarding absence of undisclosed material information.
Director Thomas N. Bohjalian purchased 10,000 shares of Healthcare Realty Trust Inc (ticker HR) on 08/13/2025 at $16.46 per share. After the transaction his reported direct beneficial ownership is 75,520 shares. The purchase is disclosed on a Form 4 statement of changes in beneficial ownership.
Julie F. Wilson, EVP and Chief Administrative Officer and a director of Healthcare Realty Trust Inc. (HR), reported a transaction dated 08/08/2025 related to the vesting of previously granted restricted shares. The issuer withheld 32,058 common shares to satisfy minimum tax withholding; after the withholding the reporting person’s direct beneficial ownership of common stock is shown as 128,419 shares.
The filing also records the issuance upon vesting of 106,823 LTIP Series D partnership units, described as profits interests that may convert into common partnership interests and then into common stock on a one-for-one basis; the filing shows an equivalent of 106,823 common shares underlying those units as directly beneficially owned. The Form 4 was signed under power of attorney by Andrew E. Loope.